You are currently browsing the archives for 20 June 2018.
Displaying 1 - 2 of 2 entries.

Both from the National Tumor Institute of the National Institutes of Health.

Arisaph Pharmaceuticals receives STTR grants to build up cancer drug candidates Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on advancement and discovery of novel treatments for cardiometabolic diseases and cancer, announced today that it’s been awarded a stage II Small Business Technology Transfer grant and a supplemental phase I grant, both from the National Tumor Institute of the National Institutes of Health ?cialis generique . The phase II award of $1,066,916 supports research and development for the Company's tumor-activated prodrug system for the treatment of a variety of cancers.

Dx/Rx: Human being Papilloma Virus was compiled by Don S.

Throughout the book, tables and numbers summarize important medical data and current professional culture recommendations, with salient references to more information. We wished to dispel open public myths encircling HPV and, instead, offer medical caregivers with current, easy to get at and concise info in an application they could use at work or clinic, described Dr. Dizon, who also founded the region’s first Middle for Sexuality, Fertility and Intimacy at Ladies & Infants to greatly help women with cancer.. Book on human being papilloma virus A set of oncologists in this program in Women’s Oncology at Ladies & Infants Medical center of Rhode Island recently co-authored a pocket-sized guidebook to the human being papilloma virus so physicians could make more accurate medical diagnosis and plan far better treatment for females with the virus.